Human and Bacterial Protease Activity As Prognostic Tool of Foot Infections in Diabetic Patients
NCT ID: NCT03964571
Last Updated: 2024-12-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
61 participants
INTERVENTIONAL
2019-10-09
2024-12-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Diabetic foot patients
WOUNDCHEK
fluid swab of wound and measurement of wound onto film
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
WOUNDCHEK
fluid swab of wound and measurement of wound onto film
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The patient must be a member or beneficiary of a health insurance plan
* The patient has been informed about the study objectives and purpose and their rights as a patient
* The patient is being treated in the Diabetes and Infectious Disease Department
* The patient has a chronic foot and/or heel wound classified as Grade 1-3 according to the Infectious Diseases Society of America.
Exclusion Criteria
* The subject refuses to sign the consent
* It is impossible to give the subject informed information
* The patient is under safeguard of justice or state guardianship
* The patient is pregnant or breastfeeding
* The patient has chronic foot and/or heel wound classified as Grade 4 according to the Infectious Diseases Society of America
* Patient with critical ischemia defined by PSGo \<50 mmHg or PSCh \<70 mmHg
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nīmes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean-Philippe Lavigne
Role: PRINCIPAL_INVESTIGATOR
CHU Nimes
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CH d'Alès
Alès, , France
CH de Bagnols sur Céze
Bagnols-sur-Cèze, , France
CHU de Montpellier
Montpellier, , France
CHU de Nimes
Nîmes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AOI GCS MERRI/2017/CDR-01
Identifier Type: -
Identifier Source: org_study_id